These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27723114)
1. Identification of non-reported bupropion metabolites in human plasma. Connarn JN; Luo R; Windak J; Zhang X; Babiskin A; Kelly M; Harrington G; Ellingrod VL; Kamali M; McInnis M; Sun D Biopharm Drug Dispos; 2016 Dec; 37(9):550-560. PubMed ID: 27723114 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma. Teitelbaum AM; Flaker AM; Kharasch ED J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():101-113. PubMed ID: 26963497 [TBL] [Abstract][Full Text] [Related]
3. Identification of bupropion urinary metabolites by liquid chromatography/mass spectrometry. Petsalo A; Turpeinen M; Tolonen A Rapid Commun Mass Spectrom; 2007; 21(16):2547-54. PubMed ID: 17639567 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC-MS/MS. Masters AR; McCoy M; Jones DR; Desta Z J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():201-208. PubMed ID: 26946423 [TBL] [Abstract][Full Text] [Related]
5. Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MS. Coles R; Kharasch ED J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):67-75. PubMed ID: 17656162 [TBL] [Abstract][Full Text] [Related]
6. Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine. Teitelbaum AM; Flaker AM; Kharasch ED J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():239-53. PubMed ID: 27318149 [TBL] [Abstract][Full Text] [Related]
7. Determination of bupropion and its main metabolite in rat plasma by LC-MS and its application to pharmacokinetics. Hu L; Wang Z; Xu R; Ma J; Wang X; Zhang X Pharmazie; 2011 Dec; 66(12):924-8. PubMed ID: 22312695 [TBL] [Abstract][Full Text] [Related]
8. Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers. Masters AR; Gufford BT; Lu JB; Metzger IF; Jones DR; Desta Z J Pharmacol Exp Ther; 2016 Aug; 358(2):230-8. PubMed ID: 27255113 [TBL] [Abstract][Full Text] [Related]
9. Sensitive, selective and rapid determination of bupropion and its major active metabolite, hydroxybupropion, in human plasma by LC-MS/MS: application to a bioequivalence study in healthy Indian subjects. Parekh JM; Sutariya DK; Vaghela RN; Sanyal M; Yadav M; Shrivastav PS Biomed Chromatogr; 2012 Mar; 26(3):314-26. PubMed ID: 21656534 [TBL] [Abstract][Full Text] [Related]
10. Bupropion plasma levels and CYP2D6 phenotype. Pollock BG; Sweet RA; Kirshner M; Reynolds CF Ther Drug Monit; 1996 Oct; 18(5):581-5. PubMed ID: 8885123 [TBL] [Abstract][Full Text] [Related]
11. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. Fokina VM; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN Am J Obstet Gynecol; 2016 Oct; 215(4):497.e1-7. PubMed ID: 27180885 [TBL] [Abstract][Full Text] [Related]
12. Transport of Bupropion and its Metabolites by the Model CHO and HEK293 Cell Lines. Han LW; Gao C; Zhang Y; Wang J; Mao Q Drug Metab Lett; 2019; 13(1):25-36. PubMed ID: 30488806 [TBL] [Abstract][Full Text] [Related]
13. A simple and sensitive LC-ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates. Yeniceli D; Sener E; Korkmaz OT; Doğrukol-Ak D; Tuncel N Talanta; 2011 Mar; 84(1):19-26. PubMed ID: 21315892 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy. Fokina VM; Xu M; Rytting E; Abdel-Rahman SZ; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN Drug Metab Dispos; 2016 Nov; 44(11):1832-1838. PubMed ID: 27528039 [TBL] [Abstract][Full Text] [Related]
15. HPLC assay for bupropion and its major metabolites in human plasma. Loboz KK; Gross AS; Ray J; McLachlan AJ J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):115-21. PubMed ID: 16011913 [TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender. Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710 [TBL] [Abstract][Full Text] [Related]
17. CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion. Zhu AZ; Cox LS; Nollen N; Faseru B; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF Clin Pharmacol Ther; 2012 Dec; 92(6):771-7. PubMed ID: 23149928 [TBL] [Abstract][Full Text] [Related]
18. Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers. Hesse LM; Greenblatt DJ; von Moltke LL; Court MH J Clin Pharmacol; 2006 May; 46(5):567-76. PubMed ID: 16638740 [TBL] [Abstract][Full Text] [Related]
19. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction. Reese MJ; Wurm RM; Muir KT; Generaux GT; St John-Williams L; McConn DJ Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781 [TBL] [Abstract][Full Text] [Related]
20. Steady-state clinical pharmacokinetics of bupropion extended-release in youths. Daviss WB; Perel JM; Birmaher B; Rudolph GR; Melhem I; Axelson DA; Brent DA J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1503-9. PubMed ID: 17135996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]